Literature DB >> 1851125

Superoxide production by Crohn's disease neutrophils.

F T Curran1, R N Allan, M R Keighley.   

Abstract

Neutrophil superoxide anion production was measured in healthy subjects and in patients with quiescent and active Crohn's disease using superoxide dismutase inhibitable cytochrome C reduction. Three stimuli were used: phorbol 12-myristate 13-acetate (PMA1), phorbol 20-oxo-20-deoxy 12-myristate 13-acetate (PMA2), and Candida albicans in serum. Normal neutrophils produced significantly more superoxide anion than Crohn's disease neutrophils with both PMA1 (mean (SD) 9.6 (2.2) v 8.6 (1.8) nmol/10(6) cells/5 minutes, p = 0.04) and PMA2 (1.8 (0.8) v 0.8 (0.77) nmol/10(6) cells/5 minutes, p = 0.00004). With C albicans in serum, normal and Crohn's disease neutrophils produced similar amounts of superoxide anion (4.4 (1.5) v 4.3 (1.7) nmol/10(6) cells/30 minutes, not significant). Results were independent of disease activity. Superoxide anion production by PMA-stimulated Crohn's disease neutrophils is significantly lower than by normal neutrophils.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1851125      PMCID: PMC1379079          DOI: 10.1136/gut.32.4.399

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


  27 in total

Review 1.  Polymorphonuclear leukocyte-mediated cell and tissue injury: oxygen metabolites and their relations to human disease.

Authors:  J C Fantone; P A Ward
Journal:  Hum Pathol       Date:  1985-10       Impact factor: 3.466

Review 2.  Production of superoxide by phagocytic leukocytes: a paradigm for stimulus-response phenomena.

Authors:  J A Badwey; M L Karnovsky
Journal:  Curr Top Cell Regul       Date:  1986

3.  Superoxide dismutase. An enzymic function for erythrocuprein (hemocuprein).

Authors:  J M McCord; I Fridovich
Journal:  J Biol Chem       Date:  1969-11-25       Impact factor: 5.157

4.  The metabolism of leukocytes.

Authors:  M L Karnovsky
Journal:  Semin Hematol       Date:  1968-04       Impact factor: 3.851

5.  Studies of the metabolic activity of leukocytes from patients with a genetic abnormality of phagocytic function.

Authors:  B Holmes; A R Page; R A Good
Journal:  J Clin Invest       Date:  1967-09       Impact factor: 14.808

6.  Free radicals and inflammation: protection of synovial fluid by superoxide dismutase.

Authors:  J M McCord
Journal:  Science       Date:  1974-08-09       Impact factor: 47.728

7.  Leukocyte myeloperoxidase deficiency and disseminated candidiasis: the role of myeloperoxidase in resistance to Candida infection.

Authors:  R I Lehrer; M J Cline
Journal:  J Clin Invest       Date:  1969-08       Impact factor: 14.808

8.  Chemiluminescence and superoxide production by myeloperoxidase-deficient leukocytes.

Authors:  H Rosen; S J Klebanoff
Journal:  J Clin Invest       Date:  1976-07       Impact factor: 14.808

9.  Diminished neutrophil function in Crohn's disease and ulcerative colitis identified by decreased oxidative metabolism and low superoxide dismutase content.

Authors:  H W Verspaget; A S Peña; I T Weterman; C B Lamers
Journal:  Gut       Date:  1988-02       Impact factor: 23.059

10.  Candidacidal activity of Crohn's disease neutrophils.

Authors:  F T Curran; D J Youngs; R N Allan; M R Keighley
Journal:  Gut       Date:  1991-01       Impact factor: 23.059

View more
  17 in total

Review 1.  Is Crohn's disease an immunodeficiency? A hypothesis suggesting possible early events in the pathogenesis of Crohn's disease.

Authors:  J R Korzenik; B K Dieckgraefe
Journal:  Dig Dis Sci       Date:  2000-06       Impact factor: 3.199

2.  Is Crohn's disease due to defective immunity?

Authors:  J R Korzenik
Journal:  Gut       Date:  2007-01       Impact factor: 23.059

Review 3.  Clinical relevance of oxygen radicals in inflammatory bowel disease--facts and fashion.

Authors:  H Allgayer
Journal:  Klin Wochenschr       Date:  1991-12-15

4.  Diminished cytochrome b content and toxic oxygen metabolite production in circulating neutrophils from patients with Crohn's disease.

Authors:  J A Solis-Herruzo; B Fernandez; E Vilalta-Castell; M T Muñoz-Yagüe; I Hernandez-Muñoz; M P de la Torre-Merino; J Balsinde
Journal:  Dig Dis Sci       Date:  1993-09       Impact factor: 3.199

5.  Studies on peroxisomes of colonic mucosa in Crohn's disease.

Authors:  I Aimone-Gastin; S Cable; J M Keller; M A Bigard; B Champigneulle; P Gaucher; J L Gueant; M Dauça
Journal:  Dig Dis Sci       Date:  1994-10       Impact factor: 3.199

Review 6.  Growth factors as treatment for inflammatory bowel disease: a concise review of the evidence toward their potential clinical utility.

Authors:  Josué Barahona-Garrido; Jorge Hernández-Calleros; Ignacio García-Juárez; Jesús K Yamamoto-Furusho
Journal:  Saudi J Gastroenterol       Date:  2009 Jul-Sep       Impact factor: 2.485

7.  [41-year old patient with obscure diarrhea].

Authors:  T Brünnler; F Bataille; F Hofstädter; G Birkenfeld; J Schölmerich
Journal:  Internist (Berl)       Date:  2009-09       Impact factor: 0.743

8.  p40phox expression regulates neutrophil recruitment and function during the resolution phase of intestinal inflammation.

Authors:  Kara L Conway; Gautam Goel; Harry Sokol; Monika Manocha; Emiko Mizoguchi; Cox Terhorst; Atul K Bhan; Agnès Gardet; Ramnik J Xavier
Journal:  J Immunol       Date:  2012-08-22       Impact factor: 5.422

9.  Alterations in rat peripheral blood neutrophil function as a consequence of colitis.

Authors:  L Carter; J L Wallace
Journal:  Dig Dis Sci       Date:  1995-01       Impact factor: 3.199

10.  New treatment options in the management of IBD - focus on colony stimulating factors.

Authors:  Josué Barahona-Garrido; Jesús K Yamamoto-Furusho
Journal:  Biologics       Date:  2008-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.